Orange Book product · Brand (NDA)
PLENAXIS
ABARELIX
Brand (NDA)NDA 021320DISCN SPECIALITY EUROPEAN
At a glance
Nov 25, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 25, 2003
22 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ABARELIX
Strength
100MG/VIAL
Dosage form
POWDER
Route
INTRAMUSCULAR
TE code
Not listed
Application
NDA 021320
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
